Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study.

Competing Interests: Competing interests: UTK is an MRC Clinical Training Fellow based at the University of Liverpool supported by the North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics, which is funded by the Medical Research Council (Award Ref. MR/N025989/1), Roche Pharma, Eli Lilly and Company Limited, UCB Pharma, Novartis, the University of Liverpool and the University of Manchester. AP received research funding from Celgene, Chugai, Gilead, GSK/Novartis, Roche and Verastem. NK received research funding from Celgene.